Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Influenza A M2 Protein Inhibitor [EPC]: Side Effects & Safety Data for 2 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Influenza A M2 Protein Inhibitor [EPC] includes 2 drugs with a combined 5,145 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

2
Drugs in Class
5,145
Combined Reports

All Influenza A M2 Protein Inhibitor [EPC] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
AMANTADINE Amantadine 5,135 483 1,579 9.4%
RIMANTADINE Rimantadine Hydrochloride 10 0 3 N/A

Common Side Effects in Influenza A M2 Protein Inhibitor [EPC] Drugs

Side EffectReportsDeaths
Fall 594 49
Hallucination 584 33
Drug ineffective 519 21
Dyskinesia 470 19
Dizziness 379 9
Tremor 347 7
Off label use 346 10
Gait disturbance 317 10
Fatigue 292 11
Hallucination, visual 277 7
View detailed side effects for this class → Compare drugs in this class →